Expansion of the human adipose-derived stromal vascular cell fraction yields a population of smooth muscle-like cells with markedly distinct phenotypic and functional properties relative to mesenchymal stem cells

Tissue Engineering - Part C: Methods

Volumn 17, Issue 8, 2011, Pages 843-860

  Basu, Joydeep ^a   Genheimer, Christopher W ^a   Guthrie, Kelly I ^a   Sangha, Namrata ^a   Quinlan, Sarah F ^a   Bruce, Andrew T ^a   Reavis, Bethany ^a   Halberstadt, Craig ^a   Ilagan, Roger M ^a   Ludlow, John W ^a  

^a Tengion Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOACTIVITY; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIAL CELLS; FUNCTIONAL POLYMERS; GENES; MUSCLE; POLYMERASE CHAIN REACTION; REACTION KINETICS; STEM CELLS; TRANSCRIPTION;

ADHERENT CELLS; ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE-DERIVED CELLS; ANTIGEN EXPRESSION; BIOLOGICAL PROPERTIES; CELL POPULATIONS; CELL TYPES; CELLULAR THERAPY; CYTOKINES; DATA SUPPORT; DIRECT DIFFERENTIATION; FUNCTIONAL PROPERTIES; FUNCTIONAL RESPONSE; GROWTH CONDITIONS; GROWTH FACTOR; HUMAN ADIPOSE TISSUE; IN-VITRO; INTERNATIONAL SOCIETY; MESENCHYMAL PROGENITORS; MESENCHYMAL STEM CELL; PRIMARY CELL CULTURES; PROTEIN FINGERPRINTING; QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; SMALL MOLECULES; SMOOTH MUSCLE CELLS; STROMAL CELLS; VASCULAR CELLS;

GROWTH KINETICS;

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; THROMBOXANE A2;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BIOPSY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE TECHNIQUE; CYTOLOGY; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PHENOTYPE; SMOOTH MUSCLE FIBER; STROMA CELL;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADIPOCYTES; ADIPOSE TISSUE; BIOPSY; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MESENCHYMAL STEM CELLS; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; STROMAL CELLS; THROMBOXANE A2;

EID: 79961091436     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2010.0697     Document Type: Article

References (69)

1. Dominici, M., LeBlanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
2. da Silva Meirelles, L., Chagastelles, P.C., and Nardi, N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119, 2204, 2006.
3. Crisan, M., Solomon, Y., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schuger, R., Deasy, B.M., Badylak, S., Buhring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., and Peault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
4. Jones, E., and McGonagle, D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology 47, 126, 2008.
5. Covas, D.T., Panepucci, R.A., Fontes, A.M., Silva, W.A., Jr., Orellana, M.D., Freitas, M.C., Neder, L., Santos, A.R., Peres, L.C., Jamur, M.C., and Zago, M.A. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol 36, 642, 2008.
6. Haniffa, M.A., Wang, X.N., Holtick, U., Rae, M., Isaacs, J.D., Dickinson, A.M., Hilkens, C.M., and Collin, M.P. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 179, 1595, 2007.
7. Summer, R., and Fine, A. Mesenchymal progenitor cell research: limitations and recommendations. Proc Am Thorac Soc 5, 707, 2008.
8. Koumas, L., Smith, T.J., Feldon, S., Blumberg, N., and Phipps, R.P. Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol 163, 1291, 2003.
9. Ulloa-Montoya, F., Verfaillie, C.M., and Hu, W.S. Culture systems for pluripotent stem cells. J Biosci Bioeng 100, 12, 2005.
10. Ratajczak, M.Z., Kucia, M., Majka, M., Reca, R., and Ratackzak, J. Heterogeneous populations of bone-marrow stem cells- are we spotting the same cells from the different angles? Folia Histochem Cytobiol 42, 139, 2004.
11. Lodie, T.A., Blickarz, C.E., Devarakonda, T.J., He, C., Dash, A.B., Clarke, J., Gleneck, K., Shihabuddin, L., and Tubo, R. Systematic analysis of reportedly distinct populations of multipotent bone-marrow derived stem cells reveals a lack of distinction. Tissue Eng 8, 739, 2002.
12. Montzka, K., Lassonczyk, N., Tschöke, B., Neuss, S., Führmann, T., Franzen, R., Smeets, R., Brook, G.A., and Wöltje, M. Neural differentiation potential of human bone marrowderived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci 10, 16, 2009.
13. Basu, J., and Ludlow, J.W. Platform technologies for tubular organ regeneration. Trends Biotechnol 28, 526, 2010.
14. Kaltz, N., Funari, A., Hippauf, S., Delorme, B., Noel, D., Riminucci, M., Jacobs, V.R., Haupl, T., Jorgensen, C., Charbord, P., Peschel, C., Bianco, P., and Oostendorp, R.A. In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 26, 2419, 2008.
15. Im, G.I., Shin, Y.W., and Lee, K.B. Do adipose tissue derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow cells? Osteoarthritis Cartilage 13, 845, 2005.
16. Vidal, M.A., Robinson, S.O., Lopez, M.J., Paulsen, D.B., Borkhsenious, O., Johnson, J.R., Moore, R.M., and Gimble, J.M. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg 37, 713, 2008.
17. Rebelatto, C.K., Aguiar, A.M., and Moretao, M.P. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood and adipose tissue. Exp Biol Med 233, 901, 2008.
18. Sakaguchi, Y., Sekiya, I., Yagishita, K., and Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52, 2521, 2005.
19. Wagner, W., Wein, F., Seckinger, A., Frankhauser, M., Wirkner, U., Krause, U., Blake, J., Schwager, C., Eckstein, V., Ansorge, W., and Ho, A.D. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissues, and umbilical cord blood. Exp Hematol 33, 1402, 2005.
20. Gong, Z., Calkins, G., Cheng, E.C., Krause, D., and Niklason, L.E. Influence of culture medium on smooth muscle cell differentiation from human bone marrow derived mesenchymal stem cells. Tissue Eng Part A 15, 319, 2008.
21. Lund, P., Pilgaard, L., Duroux, M., Fink, T., and Zachar, V. Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells. Cytotherapy 11, 189, 2009.
22. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113, 1161, 2000.
23. Bruder, S.P., Jaiswal, N., and Haynesworth, S.E. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64, 278, 1997.
24. Stolzing, A., Coleman, A., and Scutt, A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 9, 31, 2006.
25. Ilagan, R.M., Genheimer, C., Quinlan, S.F., Guthrie, K.I., Sangha, N., Ramachandrannair, S., Kelley, R., Presnell, S.C., Basu, J., and Ludlow, J.W. Smooth muscle phenotypic diversity is mediated through alterations in Myocardin gene splicing. J Cell Physiol; PMID: 21194112 [Epub ahead of print].
26. Boquest, A.C., Shahdadfar, A., Fronsdal, K., Sigurjonsson, O., Tunheim, S.H., Collas, P., and Brinchmann, J.E. Isolation and transcription profiling of purified uncultured human stromal cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 16, 1131, 2005.
27. Roche, S., Delorme, B., Oostendorp, R.A., Barbet, R., Caton, D., Noel, D., Boumediene, K., Papadaki, H.A., Cousin, B., Crozet, C., Milhavet, O., Casteilla, L., Hatzfeld, J., Jorgensen, C., Charbord, P., and Lehmann, S. Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. Proteomics 9, 223, 2009.
28. Noel, D., Caton, D., Roche, S., Bony, C., Lehmann, S., Casteilla, L., Jorgensen, C., and Cousin, B. Cell specific differences between human adipose derived and mesenchymal stromal cells despite similar differentiation potentials. Exp Cell Res 314, 1575, 2008.
29. Kim, M.R., Jeon, E.S., Kim, Y.M., Lee, J.S., and Kim, J.H. Thromboxane A2 induces differentiation of human mesenchymal stem cells to smooth muscle-like cells. Stem Cells 27, 191, 2009.
30. Lin, G., Garcia, M., Ning, H., Banie, L., Guo, Y.L., Lue, T.F., and Lin, C.S. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17, 1053, 2008.
31. Liu, T.M., Martina, M., and Hutmacher, D.W. Identification of common pathways mediating differentiation of bone marrow and adipose tissue derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25, 750, 2007.
32. Jack, G.S., Zhang, R., Lee, M., Xu, Y., Wu, B.M., and Rodriguez, L.V. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 30, 3259, 2009.
33. Tian, H., Bharadwaj, S., Liu, Y., Ma, P.X., Atala, A., and Zhang, Y. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials 31, 870, 2010.
34. Lai, J.Y., Yoon, C.Y., Yoo, J.J., Wulf, T., and Atala, A. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 168, 1853, 2002.
35. Hipp, J., Anderson, K.E., Kwon, T.G., Kwak, T.E., Yoo, J., and Atala, A. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int 101, 100, 2008.
36. Hipp, J.A., Hipp, J.D., Yoo, J.J., Atala, A., and Andersson, K.E. Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int 102, 741, 2008.
37. Hennig, T., Lorenz, H., Thiel, A., Goetzke, K., Dickhut, A., Geiger, F., and Richter, W. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGF-b receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211, 682, 2007.
38. Friedman, M.S., Long, M.W., and Hankenson, K.D. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98, 538, 2006.
39. Owens, G.K. Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand 164, 623, 1999.
40. Niemeyer, P., Kornacker, M., Mehlhorn, A., Seckinger, A., Vohrer, J., Schmal, H., Kasten, P., Eckstein, V., Südkamp, N.P., and Krause, U. Comparison of immunological properties of bone marrow stromal cells and adipose tissue derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng 13, 111, 2007.
41. Tintut, Y., Alfonso, Z., Saini, T., Radcliff, K., Watson, K., Boström, K., and Demer, L.L. Multilineage potential of cells from the artery wall. Circulation 108, 2505, 2003.
42. Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C.M. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615, 2001.
43. Chamberlain, G., Fox, J., Ashton, B., and Middleton, J. Concise review: mesenchymal stem cells- their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells 25, 2739, 2007.
44. Lee, R.H., Kim, B., Choi, I., Suh, K., Bae, Y.C., and Jung, J.S. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311, 2004.
45. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., and Deliliers, G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30, 783, 2002.
46. Izadpanah, R., Trygg, C., Patel, B., Kriedt, C., Dufour, J., Gimble, J.M., and Bunnell, B.A. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99, 1285, 2006.
47. Lennon, D.P., Haynesworth, S.E., Bruder, S.P., Jaiswal, N., and Caplan, A.I. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 32, 602, 1996.
48. Roche, S., Richard, M.J., and Favrot, M.C. Oct-4, Rex-1 and GATA4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem 101, 271, 2007.
49. Jager, M., Wild, A., Lensing-Hohn, S., and Krauspe, R. Influence of different culture solutions on osteoblastic differentiation in cord blood and bone marrow derived progenitor cells. Biomed Tech (Berl) 48, 241, 2003.
50. Kume, S., Kato, S., Yamagishi, S., Inagaki, Y., Ueda, S., Arima, N., Okawa, T., Kojiro, M., and Nagata, K. Advanced glycation end products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage and bone. J Bone Miner Res 20, 1647, 2005.
51. Kim, Y.M., Jeon, E.S., Kim, M.R., Lee, J.S., and Kim, J.H. Bradykinin-induced expression of alpha-smooth muscle actin in human mesenchymal stem cell. Cell Signal 20, 1882, 2008.
52. Jeon, E.S., Moon, H.J., Lee, M.J., Song, H.Y., Kim, Y.M., Bae, Y.C., Jung, J.S., and Kim, J.H. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth muscle like cells through a TGF-beta dependant mechanism. J Cell Sci 119, 4994, 2006.
53. Kim, Y.M., Jeon, E.S., Kim, M.R., Jho, S.K., Ryu, S.W., and Kim, J.H. Angiotensin II-induced differentiation of adipose tissue derived mesenchymal stem cells to smooth muscle cells. Int J Biochem Cell Biol 40, 2482, 2008.
54. Xu, W., Zhang, X., Qian, H., Zhu, W., Sun, X., Hu, J., Zhou, H., and Chen, Y. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 229, 623, 2004.
55. Sakuma, T., Matsumoto, T., Kano, K., Fukuda, N., Obinata, D., Yamaguchi, K., Yoshida, T., Takahashi, S., and Mugishima, H. Mature, adipocyte derived, dedifferentiated fat cells can differentiate into smooth muscle like cells and contribute to bladder tissue regeneration. J Urol 182, 16, 2009.
56. Kanematsu, A., Yamamoto, S., Iwai-Kanai, E., Kanatani, I., Imamura, M., Adam, R.M., Tabata, Y., and Ogawa, O. Induction of smooth muscle cell like phenotype in marrow derived cells among regenerating urinary bladder smooth muscle cells. Am J Pathol 166, 565, 2005.
57. Becker, C., Laeufer, T., Arikkat, J., and Jakse, G. TGFbeta1 and epithelial-mesenchymal interactions promote smooth muscle gene expression in bone-marrow stromal cells: possible application in therapies for urological defects. Int J Artif Organs 31, 951, 2008.
58. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767, 2004.
59. Shukla, D., Box, G.N., Edwards, R.A., and Tyson, D.R. Bone marrow stem cells for urologic tissue engineering. World J Urol 26, 341, 2008.
60. Wamhoff, B.R., Bowles, D.K., and Owens, G.K. Excitationtranscription coupling in arterial smooth muscle. Circ Res 98, 868, 2006.
61. Yoshida, T., and Owens, G.K. Molecular determinants of vascular smooth muscle cell diversity. Circ Res 18, 280, 2009.
62. Caplan, A.I. Why are MSCs therapeutic? New data: new insight. J Pathol 217, 318, 2009.
63. Caplan, A.I. New era of cell-based orthopedic therapies. Tissue Eng Part B 15, 195, 2009.
64. da Silva Meirelles, L., Sand, T.T., Harman, R.J., Lennon, D.P., and Caplan, A.I. MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A 15, 221, 2009.
65. Krenning, G., Moonen, J.R., van Luyn, M.J., and Harmsen, M.C. Generating new blood flow: integrating developmental biology and tissue engineering. Trends Cardiovasc Med 18, 312, 2008.
66. Krenning, G., Moonen, J.R., van Luyn, M.J., and Harmsen, M.C. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial to mesenchymal transdifferentiation on collagen matrices. Biomaterials 29, 3703, 2008.
67. He, Q., Chao, W., and Li, G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25, 69, 2007.
68. Dennis, J.E., and Charbord, O. Origin and differentiation of human and murine stroma. Stem Cells 20, 205, 2002.
69. Genheimer, C.W., Guthrie, K.I., Shokes, J.E., Bruce, A.T., Quinlan, S.F., Sangha, N., Ilagan, R.M., Basu, J., Burnette, T., and Ludlow, J.W. Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach. Appl Immunohistochem Mol Morphol 19, 184, 2011.